throbber
Mangrove Partners
`
`645 Madison Avenue
`14th Floor
`New York, NY 10022
`http://www.mangrovepartners.com
`
`
`
`March 27, 2015
`
`
`This Brochure provides information about the qualifications and business practices of Mangrove
`Partners (“Mangrove” or the “Firm”). Mangrove is an investment adviser registered with the
`Securities and Exchange Commission (the “SEC”). The information in this brochure has not been
`approved or verified by the SEC or by any state securities authority. Registration of an
`investment adviser does not imply any level of skill or training. The oral and written
`communications of an adviser provide you with information with which you can determine
`whether you wish to hire or retain such adviser.
`
`This document is not an advertisement, an offer to sell or the solicitation of an offer to purchase
`interests in any fund managed by Mangrove. Offers to invest in any such interests or accounts
`may be made only pursuant to appropriate offering documents. Investors must be qualified and
`approved prior to investing.
`
`If you have any questions about the contents of this Brochure, please contact us at (212) 897-
`9535 or compliance@MangrovePartners.com.
`
`information about Mangrove
`Additional
`www.adviserinfo.sec.gov.
`
`the SEC’s website at
`
`is available on
`
`
`
`
`
`VIRNETX EXHIBIT 2001
`Mangrove v. VirnetX
`Trial IPR2015-01046
`
`Page 1 of 17
`
`

`
`Mangrove Partners
`
`Item 2: Material Changes
`
`
`Since our last Brochure dated March 31, 2014, we have made certain updates to the information
`contained in the Brochure. The following summary is a list of only those changes that we deem
`as material in nature.
`
`Assets under management (AUM) information has been updated to reflect values as of January
`1, 2015.
`
`
`
`2
`
`Page 2 of 17
`
`

`
`Mangrove Partners
`
`Item 3: Table of Contents
`
`ITEM 2: MATERIAL CHANGES
`ITEM 4: ADVISORY BUSINESS
`ITEM 5: FEES AND COMPENSATION
`ITEM 6: PERFORMANCE-BASED FEES AND SIDE-BY-SIDE MANAGEMENT
`ITEM 7: TYPES OF CLIENTS
`ITEM 8: METHODS OF ANALYSIS, INVESTMENT STRATEGIES AND RISK OF LOSS
`ITEM 9: DISCIPLINARY INFORMATION
`ITEM 10: OTHER FINANCIAL INDUSTRY ACTIVITIES AND AFFILIATIONS
`ITEM 11: CODE OF ETHICS, PARTICIPATION OR INTEREST IN CLIENT TRANSACTIONS
`AND PERSONAL TRADING
`ITEM 12: BROKERAGE PRACTICES
`ITEM 13: REVIEW OF ACCOUNTS
`ITEM 14: CLIENT REFERRALS AND OTHER COMPENSATION
`ITEM 15: CUSTODY
`ITEM 16: INVESTMENT DISCRETION
`ITEM 17: VOTING CLIENT SECURITIES
`ITEM 18: FINANCIAL INFORMATION
`
`
`2
`3
`4
`6
`6
`6
`12
`13
`
`13
`14
`16
`16
`16
`17
`17
`17
`
`Item 4: Advisory Business
`
`Mangrove Partners, a Cayman Islands exempted company established in 2010, provides
`investment management services on a discretionary basis to the Funds (defined below) which
`are privately offered pooled investment vehicles intended for sophisticated individual and
`institutional investors. (Mangrove Partners is referred to as “Mangrove” or the “Firm” in this
`Brochure and references to “us”, “we” and “our” also refer to Mangrove.)
`
`Mangrove is the investment manager for The Mangrove Partners Fund, L.P., a Delaware limited
`partnership (the “US Feeder”), The Mangrove Partners Fund (Cayman), Ltd., a Cayman Islands
`exempted company (the “Cayman Feeder”), The Mangrove Partners Master Fund, Ltd., a
`Cayman Islands exempted company (the “Cayman Master”) and MP OpportunityCo 1, LLC
`(“MPOC1”), a Delaware limited liability company. (Each of the foregoing funds is referred to
`individually as a “Fund” and collectively as the “Funds”. “Investor” refers to any investor in any
`of the Funds.)
`
`An affiliate of Mangrove, Mangrove Capital, a Cayman Islands exempted company (“Mangrove
`Capital”), serves as the general partner of the US Feeder and the managing member to MPOC1.
`The US Feeder and the Cayman Feeder are constituents of a “master-feeder” structure for which
`
`
`
`3
`
`Page 3 of 17
`
`

`
`Mangrove Partners
`
`the Cayman Master serves as the master fund. Each of the Funds is exempt from the registration
`requirements of the Investment Company Act of 1940 (the “Investment Company Act”).
`
`The Funds’ shared investment objective is to organically compound their net worth while
`minimizing the chances of a permanent loss of capital. Mangrove’s investment strategy
`concentrates on an
`identified subset of systematically underfollowed
`investments and
`inefficient markets. Our goal is to generate positive returns from both long and short
`investments as opposed to employing a relative value or market hedging strategy. Our
`investment process involves in-depth analysis and valuation work at the company level while
`being cognizant of underlying industry dynamics. Our deep value discipline in combination with
`our focus on underfollowed securities gives us our edge.
`
`Mangrove neither tailors its advisory services to the individual needs of investors in the Funds
`(“Investors”), nor accepts investor-imposed investment restrictions.
`
`For further details on the Mangrove’s investment strategy, please see Item 7 (“Types of Clients”)
`and Item 8 (“Methods of Analysis, Investment Strategies and Risk of Loss”) below.
`
`The principal owner of Mangrove is Nathaniel August.
`
`As of January 1, 2015, Mangrove manages approximately $449,210,433 of client assets, in net
`equity terms, on a discretionary basis. Mangrove does not currently manage any client assets on
`a non-discretionary basis.
`
`Item 5: Fees and Compensation
`
`Management Fees
`
`Other than MPOC1, Mangrove receives fees for its advisory services based on a percentage
`(generally, approximately 2% annually) of assets under management. In general, Mangrove
`deducts fees from Fund assets. Management fees are payable monthly in advance and are
`calculated by a third party administrator. Management fees are prorated for any month during
`which Mangrove does not serve as investment manager for the entire month. Mangrove has
`discretion to waive, reduce or rebate management fees.
`
`Performance-Based Compensation
`
`Except for MPOC1, Mangrove Capital is allocated 20% of the annual increase in the net worth of
`an Investor’s interest in a Fund (the “Performance Allocation”). If, however, there is a decrease
`in the net worth of an Investor’s interest in a Fund (other than MPOC1) at the conclusion of a
`calendar year the Performance Allocation will be reduced to 10% until the net worth of the
`Investor’s interest increases by an amount equal to twice the decrease.
`
`Mangrove Capital structures Performance Allocation subject to Section 205(a)(1) of the Advisers
`Act in accordance with the available exemptions thereunder, including the exemption set forth
`in Rule 205-3. In measuring clients’ profits for the calculation of Performance Allocation,
`Mangrove Capital includes realized and unrealized gains and losses.
`
`
`
`4
`
`Page 4 of 17
`
`

`
`Mangrove Partners
`
`
`The Performance Allocation is allocated at the end of each calendar year to a separate series of
`Cayman Master shares issued by the Cayman Master to Mangrove Capital. Mangrove Capital
`reserves the right (i) to receive such compensation in any form or manner, including from the
`Cayman Master, U.S. Feeder and/or Cayman Feeder, so long as such change does not negatively
`and adversely affect any investor and (ii) to waive, reduce or rebate the Performance Allocation
`or to pay or reallocate a portion of the Performance Allocation to certain Investors and/or other
`third parties.
`
`With respect to MPOC1, performance-based compensation is paid on a realized basis using a
`waterfall structure. Distributable cash is first allocated to investors until they have received a
`return of their capital plus an 8% preferred return. Distributable cash flow is then allocated to
`Mangrove Capital as a “catch-up” until Mangrove Capital has received an amount equal to 25%
`of the investors’ 8% preferred return. Thereafter, 80% of distributable cash is allocated to
`investors and 20% is allocated to Mangrove Capital.
`
`Other Fees and Expenses
`
`Each Fund bears, or reimburses Mangrove and its affiliates for, its organization, operating and
`investment expenses and, in the case of the US Feeder and the Cayman Feeder, their respective
`allocable share of the organization and operating expenses of the Cayman Master. Expenses and
`fees borne by the Funds include, among other things, (i) all operating and administrative fees
`and expenses of the Funds; (ii) all costs and expenses associated with the Funds’ investment
`program; (iii) all costs and expenses related to the Funds’ portfolio and trade management
`systems, risk management systems and other similar systems; (iv) all expenses related to the
`indemnification of any person; and (v) taxes, fees or other governmental charges levied against
`the Funds. Expenses and fees are allocated among the Funds in such manner as Mangrove and
`Mangrove Capital deem to be fair and reasonable.
`
`Side Letters
`
`Mangrove may from time to time enter into agreements with certain Fund investors that may
`provide for terms of investment that are more favorable than the terms described in the
`relevant Fund offering documents. Such terms may include the waiver, reduction or rebate of
`management fees, Fund expenses and/or performance-based allocations, the provision of
`additional information or reports or more favorable transfer rights. No such agreement will
`necessarily entitle any other Fund investor to the same terms of investment.
`
`Item 12 describes the factors that Mangrove considers in selecting or recommending broker-
`dealers for transactions and determining the reasonableness of their compensation (e.g.,
`commissions).
`
`No supervised person of Mangrove accepts compensation for the sale of securities or other
`investment products, including interests in or shares of the Funds.
`
`
`
`5
`
`Page 5 of 17
`
`

`
`Mangrove Partners
`
`Item 6: Performance-Based Fees and Side-By-Side Management
`
`Please see Item 5 above for a description of the performance-based compensation allocated to
`Mangrove Capital. Because a Mangrove affiliate is allocated performance-based compensation
`from each of Mangrove’s clients, Mangrove does not face the conflicts of interest that may arise
`when an investment adviser accepts performance-based fees from some clients but not from
`others. Mangrove does face conflicts that arise from the fact that the calculation of its
`performance-based compensation differs from MPOC1, on the one hand, and the other Funds,
`on the other hand.
`
`Conflicts
`
`Mangrove recognizes that these types of arrangements may create an incentive for Mangrove (i)
`to make investments on behalf of the Funds that are riskier or more speculative than would be
`the case in the absence of such an arrangements and (ii) to favor accounts for which the
`principals of Mangrove have greater personal capital investments. In order to address the
`second of these potential conflicts, Mangrove has developed and implemented the appropriate
`policies and procedures (e.g., trade allocation) to ensure that all clients are treated fairly and
`equally.
`
`Item 7: Types of Clients
`
`Mangrove provides portfolio management services to private investment funds. A minimum
`initial investment of $1,000,000 is generally required to invest in any of our private funds, with
`additional capital contributions equal to at least $50,000. However, Mangrove has discretion to
`reduce the minimum initial or additional investment to not less than $100,000 for one or more
`investors (or prospective investors) as long as they qualify to invest based on all other suitability
`and regulatory requirements.
`
`US persons must satisfy certain minimum income or asset standards in order to purchase an
`interest in a Fund.
`
`Mangrove may decline to accept an investment even if the proposed investor satisfies such
`suitability and regulatory requirements.
`
`Item 8: Methods of Analysis, Investment Strategies and Risk of
`Loss
`
`The Funds’ shared investment objective is to organically compound their net worth while
`minimizing the chances of a permanent loss of capital. Mangrove’s investment strategy
`concentrates on an
`identified subset of systematically underfollowed
`investments and
`inefficient markets. Our goal is to generate positive returns from both long and short
`investments as opposed to employing a relative value or market hedging strategy. Our
`investment process involves in-depth analysis and valuation work at the company level while
`
`
`
`6
`
`Page 6 of 17
`
`

`
`Mangrove Partners
`
`being cognizant of underlying industry dynamics. Our deep value discipline in combination with
`our focus on underfollowed securities gives us our edge.
`
`We believe that the day to day movements of markets and the valuations of securities to be
`highly inefficient as a result of the emotions of the people participating in markets and trading
`securities. Markets tend to set a dear price for the comfort of investing in familiar businesses,
`popular industries, fast-growing companies, liquid securities, and steady streams of earnings,
`dividends, and/or coupons. Conversely, market participants often overlook and undervalue
`industries that are unfashionable, securities that are small, illiquid, or not covered by brokerage
`firms, investments where there exists complexity or uncertainty on the outcome of events, the
`debt (and occasionally equity) of firms subject to bankruptcy proceedings or risk, and companies
`that are in distress, experiencing setbacks, stagnating, or declining. We believe that investors
`often confuse investments that are characterized by having uncertain outcomes, complex
`analysis, or unpopular dynamics with investments that are unsafe to own or unattractive in risk.
`
`In order to profit from these core beliefs, we build portfolios that concentrate on an identified
`subset of systematically underfollowed investments and inefficient markets. Our goal is to
`generate positive returns from both long and short investments as opposed to employing a
`relative value or market hedging strategy. Our investment process involves in-depth analysis and
`valuation work at the company level while being cognizant of underlying industry dynamics.
`Where and when we invest is driven by our deep value discipline in combination with our focus
`on underfollowed securities. Presiding over all of the investment and portfolio management
`decisions is a rigorous risk management discipline focused on taking intentional and defined
`risks at the position, industry, and portfolio level.
`
`MPOC1, unlike the other Funds, was formed and capitalized to invest, directly or indirectly, in
`the securities issued by, or instruments for which the obligor or reference asset is, one
`company. Mangrove may sponsor other funds to pursue a specific investment opportunity.
`
`The Funds are likely to devote a portion of their capital to selling securities short. Mangrove
`believes that short selling, when practiced in a disciplined manner, has the ability to
`simultaneously generate attractive returns and reduce the Funds’ market risk. The Funds will
`endeavor to sell short the securities of companies Mangrove believes are executing a flawed
`business or funding plan, capitalizing on a fad or engaging in fraud. The Funds will endeavor to
`be sensitive to the risks of engaging in short sales, including the unlimited potential for loss, the
`importance of maintaining borrow on securities sold short, and the historic (and likely future)
`broad upward price trend to securities markets. Accordingly, the Funds will employ risk controls,
`including limiting position sizes, actively trading shorted securities, and concentrating on limited
`duration short investments with anticipated catalysts.
`
`Investments in securities of any kind involve risk of loss that investors should be prepared to
`bear. The Funds may make investments or engage in certain strategies that involve specific risks
`associated with those investments or strategies, including, but not limited to the following:
`
`
`
`
`Leverage. The Funds may employ leverage, which increases both the possibilities for
`profit and the risk of loss.
`
`
`
`7
`
`Page 7 of 17
`
`

`
`Mangrove Partners
`
` Short Sales. The Funds may sell short. Selling short risks losing an amount greater than
`the proceeds received. Theoretically, securities or other financial instruments sold short
`are subject to unlimited risk of loss because there is no limit on the price that such
`security or other financial instrument may appreciate before the short position is closed.
`In addition, the supply of securities and other financial instruments that can be
`borrowed fluctuates from time to time. The Funds may be subject to losses if a lender
`demands return of the lent security or other financial instrument and an alternative
`lending source cannot be found or if the Funds are otherwise unable to borrow when
`necessary to cover their positions.
` Distressed Investing. The Funds may invest in equities or other securities of companies
`that are experiencing significant financial or business difficulties, including companies
`involved in debt restructurings, in bankruptcy or other reorganization and liquidation
`proceedings. Although such investments may result in significant returns, they typically
`involve a high degree of risk. Among the problems involved in investments in such
`issuers is the fact that it frequently may be difficult to obtain information as to the
`conditions of such issuers.
` Small and Medium Capitalization. The Funds may invest in the securities of companies
`with small to medium sized market capitalizations. While Mangrove believes that such
`companies may provide significant potential for appreciation, such securities generally
`involve higher risk in some respect than the securities of larger capitalization companies.
` Derivatives. The Funds may invest in derivative instruments, or “derivatives,” which
`include futures, options, puts, contracts for difference, swaps, structured securities and
`other instruments and contracts that are derived from, or the value of which is related
`to, one or more underlying securities, financial benchmarks, currencies, or indices. The
`value of a derivative depends largely upon price movements in the underlying asset.
`Therefore, many of the risks applicable to trading the underlying asset are also
`applicable to derivatives of such asset. However, there are a number of other risks
`associated with derivatives trading. For example, because many derivatives are
`“leveraged,” and thus provide significantly more market exposure than the money paid
`or deposited when the transaction is entered into, a relatively small adverse market
`movement can not only result in the loss of the entire investment, but may also expose
`the Funds to the possibility of a loss exceeding the original amount invested. Derivatives
`may also expose investors to liquidity risk, as there may not be a liquid market within
`which to close or dispose of outstanding derivatives contracts, and to counterparty risk.
` Real Estate. The Funds may invest in real estate. Real estate investments generally will
`be subject to the risks incident to the ownership and operation of commercial real
`estate, including (i) risks associated with the domestic and international general
`economic climate; (ii) local real estate conditions; (iii) risks due to dependence on cash
`flow; (iv) risks and operating problems arising out of the absence of certain construction
`materials; (v) changes in supply of, or demand for, competing properties in an area (as a
`result, for instance, of overbuilding); (vi) the financial condition of tenants, buyers and
`sellers of property; (vii) changes in availability of debt financing; (viii) energy and supply
`shortages; (ix) changes in the tax, real estate, environmental and zoning laws and
`regulations; (x) various uninsured or uninsurable risks; (xi) natural disasters; and (xii) the
`ability of the Funds to manage the real properties.
`
`
`
`8
`
`Page 8 of 17
`
`

`
`Mangrove Partners
`
` Private Equity and Private Debt Securities. The Funds may invest in private equity and
`private debt securities which involve an extraordinarily high degree of business and
`financial risk and can result in substantial or complete losses. Some portfolio companies
`in which the Funds invest may be operating at a loss or with substantial variations in
`operating results from period to period and may need substantial additional capital to
`support expansion or to achieve or maintain competitive positions.
`
`
`
`Litigation & Regulatory Based Investments. The Funds may invest in securities that
`depend upon favorable legal or regulatory rulings. There is no guarantee that any
`litigation will be successful, or that the issuer will obtain a favorable regulatory ruling.
` Arbitrage Investments. The Funds may engage in various types of arbitrage and relative
`value trading strategies. These strategies are based on the apparent presence of pricing
`inefficiencies and the expectation that these anomalies will revert to historical averages
`over time.
` Concentration of Holdings. Other than with respect to MPOC1 which pursues a highly
`concentrated strategy, while Mangrove intends to allocate the other Funds’ equity
`among a number of investments, there are no fixed allotments. At any given time, the
`Funds’ assets may become, and in the case of MPOC1, are, highly concentrated within a
`particular company, industry, asset category, trading style or financial or economic
`market. In that event, the Funds’ portfolio will be, and in the case of MPOC1, are, more
`susceptible to fluctuations in value resulting from adverse economic conditions affecting
`the performance of that particular company, industry, asset category, trading style or
`financial or economic market, than a less concentrated portfolio would be. Therefore,
`although the Funds (other than MPOC1) seek a diversified portfolio, there is a risk that
`one of the investments may have a disproportionate share of the Funds’ assets and/or
`that the Funds’ portfolio will be concentrated and more susceptible to adverse
`conditions, poor investment decisions or other factors which negatively affect the
`performance of the Fund. As a result, if the Funds’ (other than MPOC1) investment
`portfolio becomes concentrated, its aggregate return may be volatile and may be
`affected substantially by the performance of only one or a few holdings. Concentrated
`holdings may also subject the Funds to specific risks in the industries in which the
`investment operates. With respect to MPOC1, because its investment portfolio is
`concentrated, its aggregate return may be volatile and will be affected substantially by
`the performance of the Target and the industry in which it operates.
` Catalyst and Event Driven Investing. The Funds may invest in securities of companies
`which it believes will likely engage in, or are potential candidates for, extraordinary
`events, including, but not limited to, mergers, liquidations, bankruptcies, restructurings
`or recapitalizations, spin-offs or carve-outs and tender offers. Such securities may have
`significant exposure to overall market movements.
` Activist Strategy. The Funds may effect shareholder activism strategies, which activism
`may not be successful and may result in significant costs and expenses. If Mangrove
`concludes the commitment of time, energy and capital is justified in light of the
`potential for reward, it may seek to be a catalyst to realize value from a targeted
`investment (a “Target”) by taking an active role in effectuating corporate change either
`working alone or in conjunction with other investors. These activist techniques may
`include working with management of a Target or other more aggressive steps such as
`
`
`
`9
`
`Page 9 of 17
`
`

`
`Mangrove Partners
`
`acquiring substantial publicly disclosed stakes in a Target, proposing a restructuring,
`recapitalization, sale, or other change in strategic direction, seeking potential acquirers,
`engaging in proxy contests, making tender offers, changing management and other
`related activities. In pursuit of an activist strategy, the Investment Manager may
`determine to use litigation as a course of action. The Funds may be parties to lawsuits
`initiated by third parties, including the Target, other shareholders, or governmental
`bodies. There can be no assurance that any litigation, once begun, will be resolved in
`favor of the Funds. As a result, the Funds may be exposed to the risk of monetary
`damages and other sanctions or remedies. In addition, as an activist investor, the Funds
`are subject from time to time (and especially in the context of a proxy contest) to formal
`or informal investigations or inquiries by the SEC and other governmental and self-
`regulatory organizations in connection with its activities. Litigation and regulatory
`investigations may require significant amounts of Mangrove’s time and result in
`significant expenses to the Funds. The Funds may take controlling stakes in Targets.
`Activist investments may involve a number of risks, such as the risk of liability for
`environmental damage, product defect, failure to supervise management, violation of
`governmental regulations and other types of liability in which the limited liability
`characteristic of business operations may be ignored. In addition, in connection with the
`disposition of this investment, the Funds may make representations and warranties
`about such investment’s business and financial affairs typical of those made in
`connection with the sale of any business, or may be responsible for the contents of
`disclosure documents under applicable securities law. The Funds may also be required
`to indemnify the purchasers of such investment or underwriters to the extent that any
`such representations and warranties or disclosure documents turn out to be incorrect,
`inaccurate or misleading. All of these risks or arrangements may create contingent or
`actual liabilities and materially affect the Funds and any investment in the Funds.
` Risk Arbitrage Investments. Risk arbitrage strategies attempt to exploit merger activity
`to capture (or sell short) the spread between current market values of securities and
`their values after successful completion of a merger, restructuring or similar corporate
`transaction. Merger arbitrage
`investments often
`incur significant
`losses when
`anticipated merger or acquisition transactions are not consummated.
` Hedging Transactions. Mangrove may utilize a variety of financial instruments, such as
`derivatives, options, interest rate swaps, caps and floors, futures and forward contracts,
`both for investment purposes and for risk management purposes in order to: (i) protect
`against possible changes in the market value of the investment portfolios resulting from
`fluctuations in the securities markets and changes in interest rates, (ii) protect against
`the reduction of unrealized gains in the value of the investment portfolios, (iii) facilitate
`the sale of any such investments, (iv) enhance or preserve returns, spreads or gains on
`any investment, (v) hedge the interest rate or currency exchange rate on any liability or
`asset, (vi) protect against any increase in the price of any securities Mangrove
`anticipates purchasing at a later date or (vii) for any other reason that Mangrove deems
`appropriate. Mangrove is not required to hedge portfolio positions and may determine
`not to do so. Furthermore, Mangrove may not anticipate a particular risk so as to hedge
`against it. While Mangrove may enter into hedging transactions to seek to reduce risk,
`such transactions may result in a poorer overall performance for the Funds than if it had
`not engaged in any such hedging transaction.
`
`
`
`10
`
`Page 10 of 17
`
`

`
`Mangrove Partners
`
`
`
`Loans of Portfolio Securities. The Funds may lend their portfolio securities. In the event
`of the bankruptcy of the other party to a securities loan, the Funds could experience
`delays in recovering the loaned securities. The Funds could experience a loss if such
`securities are not recovered.
` Counterparty Creditworthiness. The Funds may engage in transactions in securities and
`other financial instruments that may involve counterparties, and no counterparty
`exposure limits have been imposed on these transactions. Any nonperformance,
`whether due to insolvency, bankruptcy or other causes, could subject the Funds to
`substantial losses.
` Non-U.S. Investments. The Funds may
`in securities and other financial
`invest
`instruments on markets located outside the United States, including, without limitation,
`in non-U.S. markets. Such investments require consideration of certain risks not typically
`associated with investing in securities or other financial instruments traded in the
`United States, including, without limitation, unfavorable currency exchange rate
`developments, restrictions on repatriation of investment income and capital, imposition
`of exchange control regulation, confiscatory taxation and economic or political
`instability in foreign nations. Liquidity and trading costs can vary significantly over time
`and across markets, particularly in emerging market countries. Non-U.S. trading costs
`generally are higher than in the United States. Non-U.S. settlement procedures and
`trade regulations may involve certain risks (such as delay in payment or delivery of
`securities or in the recovery of assets held abroad) and expenses not present in the
`settlement of domestic investments. In addition, legal remedies available to investors in
`certain foreign countries may be more limited than those available to investors in the
`United States or in other foreign countries. The laws of some foreign countries may limit
`the ability to invest in, or repatriate investments in, non-U.S. securities or other financial
`instruments. In addition, there may be less publicly available information about certain
`non-U.S. companies than would be the case for comparable companies in the United
`States, and certain non-U.S. companies may not be subject to accounting, auditing and
`financial reporting standards and requirements comparable to or as uniform as those of
`U.S. companies.
` American Depositary Receipt and Global Depositary Receipt Securities. The Funds may
`invest
`in sponsored or unsponsored American Depositary Receipts and Global
`Depositary Receipts typically issued by a bank or trust company which evidence
`ownership of underlying Securities issued by a corporation. Generally, Depositary
`Receipts in registered form are designed for use in the US Securities market and
`Depositary Receipts in bearer form are designed for use in Securities markets outside
`the United States. Depositary Receipts may not necessarily be denominated in the same
`currency as the underlying Securities into which they may be converted. Depositary
`Receipts may be issued pursuant to sponsored or unsponsored programs. In sponsored
`programs, an issuer has made arrangements to have its Securities trade in the form of
`Depositary Receipts. In unsponsored programs, the issuer may not be directly involved
`in the creation of the program. Although regulatory requirements with respect to
`sponsored and unsponsored programs are generally similar, in some cases it may be
`easier to obtain financial information from an issuer that has participated in the creation
`of a sponsored program. Accordingly, there may be less information available regarding
`issuers of Securities' underlying unsponsored programs and there may not be a
`
`
`
`11
`
`Page 11 of 17
`
`

`
`Mangrove Partners
`
`correlation between such information and the market value of the Depositary Receipts.
` Currency Risk. The Funds may make investments denominated in one or more
`currencies other than U.S. Dollars. Mangrove may, to the degree it deems appropriate,
`cause the Funds to enter into arrangements in an attempt to hedge the exposure to
`significant currency fluctuations between the U.S. Dollar and the applicable currency or
`currencies. Such arrangements may subject the Funds to additional transaction costs.
`However, price movements of currencies are difficult to predict accurately because they
`are influenced by, among other things, changing supply and demand relationships;
`governmental, trade, fiscal, monetary and exchange control programs and policies;
`national and international political and economic events; and changes in interest rates.
`Governments from time to time intervene in certain markets in order to influence prices
`directly. Accordingly, Mangrove cannot guarant

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket